NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 323 filers reported holding NATERA INC in Q1 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $47,087,776 | +13.9% | 1,064,131 | +25.2% | 0.72% | +26.5% |
| Q2 2023 | $41,342,583 | +108.8% | 849,622 | +138.3% | 0.57% | +72.6% |
| Q1 2023 | $19,796,573 | +34.6% | 356,567 | -2.6% | 0.33% | +19.7% |
| Q4 2022 | $14,708,708 | -7.5% | 366,162 | +0.9% | 0.27% | -1.1% |
| Q3 2022 | $15,899,000 | +27.9% | 362,822 | +3.5% | 0.28% | +24.8% |
| Q2 2022 | $12,429,000 | -74.2% | 350,697 | -70.4% | 0.22% | -50.2% |
| Q1 2022 | $48,255,000 | -65.7% | 1,186,198 | -21.3% | 0.45% | -44.3% |
| Q4 2021 | $140,769,000 | -16.7% | 1,507,324 | -0.6% | 0.80% | -8.6% |
| Q3 2021 | $168,964,000 | -4.2% | 1,516,192 | -2.4% | 0.88% | +1.2% |
| Q2 2021 | $176,454,000 | +16.6% | 1,554,246 | +4.3% | 0.87% | +6.1% |
| Q1 2021 | $151,339,000 | +2.9% | 1,490,435 | +0.9% | 0.82% | +11.8% |
| Q4 2020 | $147,008,000 | +52.2% | 1,477,173 | +10.5% | 0.73% | +22.7% |
| Q3 2020 | $96,569,000 | +63.0% | 1,336,778 | +12.5% | 0.60% | +28.2% |
| Q2 2020 | $59,248,000 | +73.7% | 1,188,281 | +4.0% | 0.46% | +13.4% |
| Q1 2020 | $34,114,000 | -12.4% | 1,142,453 | -1.2% | 0.41% | +1.2% |
| Q4 2019 | $38,954,000 | +706.7% | 1,156,246 | +685.3% | 0.40% | +634.5% |
| Q3 2019 | $4,829,000 | +366.6% | 147,231 | +240.5% | 0.06% | +400.0% |
| Q3 2018 | $1,035,000 | +176.7% | 43,243 | +35.4% | 0.01% | +57.1% |
| Q4 2016 | $374,000 | +5.4% | 31,933 | 0.0% | 0.01% | +16.7% |
| Q3 2016 | $355,000 | +2.0% | 31,933 | -0.8% | 0.01% | 0.0% |
| Q4 2015 | $348,000 | -66.5% | 32,191 | -66.4% | 0.01% | -62.5% |
| Q3 2015 | $1,039,000 | – | 95,789 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |